Dr. Agarwal's Health Care Limited (NSE: AGARWALEYE), ISIN INE943P01029 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AGARWALEYE last traded at ₹489.55 (-0.53%), with a 52-week range of ₹402.10 to ₹567.80 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 32.34%, FIIs 57.96%, DIIs 7.72%, mutual funds 6.02%.
EquiSense Score (ECS): 81/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.